OpenToolslogo
ToolsExpertsSubmit a Tool
AdvertiseLearn AI
  1. home
  2. news
  3. tags
  4. medicare

medicare

10+ articles
AIBernie SandersCongressDOGEDepartment of Government Efficiency
Loading news...

Related Topics

AIBernie SandersCongressDOGEDepartment of Government EfficiencyDonald TrumpEconomic ImpactEconomicsEli LillyElon Musk

Most Read

1
CMS Shakes Up Healthcare with AI and Tech Innovations Aiming for 2026
2
Trump Administration Strikes Major Deal with Pharma Giants: Ozempic Prices Slashed!
3
US Government Shutdown Day 3: Layoff Fears Loom as White House Warns Workforce
4
Dr. Oz's Billion-Dollar Prescription: Reforming America's Healthcare System
5
Elon Musk's DOGE: Why Cutting Costs Doesn't Cut It

Stay in the loop

Weekly updates on tools, models, and the companies building them.

Subscribe free

Footer

Company name

The right AI tool is out there. We'll help you find it.

LinkedInX

Knowledge Hub

  • News
  • Resources
  • Newsletter
  • Blog
  • AI Tool Reviews
  • YouTube Summary
  • YouTube Transcript Generator

Industry Hub

  • AI Companies
  • AI Tools
  • AI Models
  • MCP Servers
  • AI Tool Categories
  • Top AI Use Cases

For Builders

  • Submit a Tool
  • Experts & Agencies
  • Advertise
  • Compare Tools
  • Favourites

Legal

  • Privacy Policy
  • Terms of Service

© 2026 OpenTools - All rights reserved.

CMS Shakes Up Healthcare with AI and Tech Innovations Aiming for 2026

The Centers for Medicare & Medicaid Services (CMS) is fast-tracking AI and tech innovations, setting ambitious goals for 2026. With new models like WISeR and ACCESS, CMS targets improved patient access, reduced waste, and outcome-aligned payments. These initiatives push AI in healthcare to the next level, promising advancements in chronic care and efficiency.

Jan 23
CMS Shakes Up Healthcare with AI and Tech Innovations Aiming for 2026

Trump Administration Strikes Major Deal with Pharma Giants: Ozempic Prices Slashed!

In an unprecedented move, President Trump has announced a landmark deal with Novo Nordisk and Eli Lilly to significantly reduce the prices of popular GLP-1 medications, including Ozempic and Wegovy. These drugs, crucial for diabetes and obesity treatment, will see slashed prices for Medicare, Medicaid, and cash-paying patients, all part of the new TrumpRx initiative aimed at broadening access and alleviating drug costs. The deal reflects a pivotal shift in U.S. healthcare policy with far-reaching implications for patients and the pharmaceutical industry.

Nov 15
Trump Administration Strikes Major Deal with Pharma Giants: Ozempic Prices Slashed!

US Government Shutdown Day 3: Layoff Fears Loom as White House Warns Workforce

The 2025 United States federal government shutdown enters its third day as the White House cautions about possible widespread layoffs of federal employees if the stalemate persists. Starting on October 1, 2025, due to unresolved budgetary disputes, the shutdown has left 800,000 employees furloughed and 700,000 working without pay. Critical services remain operational, but many others are paralyzed, intensifying the pressure on Congress to strike a deal. With tensions high and the economic impact looming large, both sides blame the other for the impasse.

Oct 3
US Government Shutdown Day 3: Layoff Fears Loom as White House Warns Workforce

Dr. Oz's Billion-Dollar Prescription: Reforming America's Healthcare System

Discover how Dr. Mehmet Oz, as the new CMS Administrator, is set to save the U.S. government billions through innovative reforms in Medicaid and Medicare management.

Sep 2
Dr. Oz's Billion-Dollar Prescription: Reforming America's Healthcare System

Elon Musk's DOGE: Why Cutting Costs Doesn't Cut It

In a thought-provoking article, Forbes discusses Elon Musk's hypothetical Department of Government Efficiency (DOGE) and the paradox that even successful cost-cutting won't shrink government size. The article delves into how Congress might simply reallocate savings, using Medicare's growth as a cautionary tale. Is debating old programs better than creating new ones? Find out why reform may trump new initiatives.

Jun 22
Elon Musk's DOGE: Why Cutting Costs Doesn't Cut It

President Trump's New Exec Order Targets Outrageous Drug Prices!

President Trump’s latest executive order aims to peg U.S. drug prices to the lowest in developed nations. This ambitious directive, however, faces skepticism from industry experts due to past legal setbacks and current economic challenges. With Trump's promise of drastic price cuts ranging from 30% to 80%, the pharmaceutical industry and analysts remain wary of the feasibility of these measures.

May 18
President Trump's New Exec Order Targets Outrageous Drug Prices!

Krugman Claps Back at Musk: Social Security and Medicare Are Secure!

Economist Paul Krugman has critiqued Elon Musk's views on the sustainability of Social Security and Medicare, as well as immigration policy. Krugman counters Musk's doomsday outlook with a reassuring take on these programs' financial health and the importance of immigrants in bolstering them. Meanwhile, Musk's doom-filled speeches on declining birth rates apparently fell on skeptical ears. Find out how Krugman schools the Tesla titan on economic longevity!

May 7
Krugman Claps Back at Musk: Social Security and Medicare Are Secure!

Trump Joins Forces with Musk to Combat Social Security Fraud Amid Heated Debate

President Trump has signed a memorandum aimed at tackling Social Security and Medicare fraud, aligning with Elon Musk's calls to address purported widescale misconduct. The measure targets fraud prevention among undocumented immigrants and older recipients with mismatched records. Critics label this as an expensive response to a minor issue, with minimal documented fraud in the system. The move has sparked significant controversy, with potential impact on the Social Security Administration's operations and accessibility for vulnerable individuals.

Apr 16
Trump Joins Forces with Musk to Combat Social Security Fraud Amid Heated Debate

Bernie Sanders Calls Out Big Pharma: Profit Over People?

In a fiery Instagram Reel, Bernie Sanders takes a swing at pharmaceutical companies, accusing them of prioritizing profit margins over providing affordable medication. The reel, packed with stark statistics, prompts viewers to demand a reduction in exorbitant drug prices in the U.S. Discover Sanders' proposals and the ongoing debate in the pharmaceutical world.

Apr 16
Bernie Sanders Calls Out Big Pharma: Profit Over People?

Hands Off! America Takes to the Streets Against Trump and Musk

In an unprecedented wave of activism, millions of Americans joined over 1,400 'Hands Off' protests across all 50 states, targeting the policies of President Donald Trump and Elon Musk. The mass demonstrations, focused on criticizing the administration's approach to social programs and perceived favoritism towards the wealthy, underline growing public dissent and economic concerns. While the White House defends its policies, protesters continue to rally for social security and democratic values.

Apr 7
Hands Off! America Takes to the Streets Against Trump and Musk